Welcome to our dedicated page for Ashland SEC filings (Ticker: ASH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ashland Inc. files regular SEC disclosures that reveal how the company's specialty chemicals business performs across distinct market segments. For specialty chemical manufacturers, segment-level financial breakdowns matter significantly because pharmaceutical ingredients, personal care formulations, and industrial additives operate under different margin structures and market dynamics. The company's 10-K annual reports detail these segment economics, showing which business lines drive profitability and where operational challenges exist.
Investors analyzing Ashland's filings typically focus on several disclosure areas unique to specialty chemicals. Revenue breakdowns by end market reveal exposure to pharmaceutical, personal care, coatings, and construction industries. Geographic revenue splits indicate regional demand patterns and currency exposure. Raw material sourcing discussions highlight supply chain dependencies, particularly important for specialty chemical feedstocks with limited supplier bases. Manufacturing footprint descriptions show facility locations and capacity utilization trends affecting operational efficiency.
Our platform provides AI-powered analysis of Ashland's quarterly 10-Q reports, annual 10-K filings, and proxy statements. When executives file Form 4 insider transaction reports, these appear immediately, letting you track whether leadership buys or sells shares. Material events disclosed through 8-K filings surface operational changes, strategic announcements, and corporate developments between scheduled earnings releases. For a diversified specialty chemicals company like Ashland, these interim disclosures often contain significant operational updates affecting specific business segments.
SEC filings for chemical manufacturers include technical disclosures about environmental compliance, operational safety, and regulatory matters that casual investors might overlook but that carry material financial implications. Our AI summaries highlight these elements, explaining what complex accounting treatments or footnote disclosures mean for segment profitability and cash generation. Access quarterly earnings details without reading 50-page financial statements, and track executive compensation structures through annual proxy filings to understand management incentives.
Sanat Chattopadhyay, a director of Ashland Inc. (ASH), reported an acquisition of 300 Common Stock Units under Ashland's Deferred Compensation Plan for Non-Employee Directors on 09/30/2025. Each unit is equivalent to one share of Ashland common stock and the units are payable in common stock upon the reporting person's separation from service, subject to any deferral election. After this transaction, the reporting person beneficially owns 1,425 shares/units, which includes additional units received in lieu of cash dividends. The filing is an internal, non-derivative compensation-related award that is exempt under Rule 16b-3.
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC report beneficial ownership of 3,454,646 shares of Ashland Inc. common stock, representing 7.56% of the class. The filing states they hold shared voting and shared dispositive power over the reported shares and report no sole voting or sole dispositive power.
The holders identify AQR Capital Management as a wholly owned subsidiary of AQR Capital Management Holdings and certify the securities are held in the ordinary course of business and not to effect a change in control.
FAQ
What is the current stock price of Ashland (ASH)?
What is the market cap of Ashland (ASH)?
